HomeCompareFSEN vs MRK

FSEN vs MRK: Dividend Comparison 2026

FSEN yields 13.41% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FSEN wins by $208.3K in total portfolio value
10 years
FSEN
FSEN
● Live price
13.41%
Share price
$14.09
Annual div
$1.89
5Y div CAGR
22.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$266.0K
Annual income
$90,372.52
Full FSEN calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — FSEN vs MRK

📍 FSEN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFSENMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FSEN + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FSEN pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FSEN
Annual income on $10K today (after 15% tax)
$1,140.17/yr
After 10yr DRIP, annual income (after tax)
$76,816.64/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, FSEN beats the other by $68,219.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FSEN + MRK for your $10,000?

FSEN: 50%MRK: 50%
100% MRK50/50100% FSEN
Portfolio after 10yr
$161.8K
Annual income
$50,243.15/yr
Blended yield
31.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FSEN
No analyst data
Altman Z
0.7
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FSEN buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFSENMRK
Forward yield13.41%2.81%
Annual dividend / share$1.89$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR22.4%32.7%
Portfolio after 10y$266.0K$57.7K
Annual income after 10y$90,372.52$10,113.78
Total dividends collected$220.3K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FSEN vs MRK ($10,000, DRIP)

YearFSEN PortfolioFSEN Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,342$1,641.85$11,213$373.04+$1.1KFSEN
2$15,524$2,317.98$12,667$512.06+$2.9KFSEN
3$19,946$3,335.22$14,439$708.14+$5.5KFSEN
4$26,244$4,902.00$16,640$988.16+$9.6KFSEN
5$35,459$7,378.19$19,432$1,394.07+$16.0KFSEN
6$49,345$11,403.76$23,057$1,992.90+$26.3KFSEN
7$70,953$18,153.53$27,889$2,894.79+$43.1KFSEN
8$105,779$29,859.63$34,518$4,286.29+$71.3KFSEN
9$164,106$50,922.85$43,912$6,494.35+$120.2KFSEN
10$265,966$90,372.52$57,714$10,113.78+$208.3KFSEN

FSEN vs MRK: Complete Analysis 2026

FSENStock

FS Energy and Power Fund is business development company specializing in buyouts, debt and, to a lesser extent, equity securities investments. It prefers to invest in private U.S. energy and power companies. It seeks to invest in the United States. It prefers to take a majority stake.

Full FSEN Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FSEN vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FSEN vs SCHDFSEN vs JEPIFSEN vs OFSEN vs KOFSEN vs MAINFSEN vs JNJFSEN vs ABBVFSEN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.